Evidence map›Paper›PMID 32600288›Full record

ArticleBMC neurology2020

A novel POLR3A genotype leads to leukodystrophy type-7 in two siblings with unusually late age of onset.

Rosa Campopiano, Rosangela Ferese, Stefania Zampatti, Emiliano Giardina, Francesca Biagioni, Claudio Colonnese, Diego Centonze, Marianna Storto, Fabio Buttari, Edoardo Fraviga and 4 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Frontiers in genetics · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Novel Pathogenic Variants inHuman mutation · 2024
    Article
  6. Article
  7. A Chinese patient withFrontiers in neurology · 2023
    Article
  8. Review
  9. Spinal cord-predominant neuropathology in an adult-onset case of POLR3A-related spastic ataxia.Neuropathology : official journal of the Japanese Society of Neuropathology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 1 country.

Rosa CampopianoI.R.C.C.S. I.N.M. Neuromed, via Atinense 18, 86077, Pozzilli, Italy.
Rosangela FereseI.R.C.C.S. I.N.M. Neuromed, via Atinense 18, 86077, Pozzilli, Italy.
Stefania ZampattiMolecular Genetics Laboratory UILDM, Santa Lucia Foundation IRCCS, Rome, Italy.
Emiliano GiardinaMolecular Genetics Laboratory UILDM, Santa Lucia Foundation IRCCS, Rome, Italy.
Francesca BiagioniI.R.C.C.S. I.N.M. Neuromed, via Atinense 18, 86077, Pozzilli, Italy.
Claudio ColonneseI.R.C.C.S. I.N.M. Neuromed, via Atinense 18, 86077, Pozzilli, Italy.
Diego CentonzeI.R.C.C.S. I.N.M. Neuromed, via Atinense 18, 86077, Pozzilli, Italy.
Marianna StortoI.R.C.C.S. I.N.M. Neuromed, via Atinense 18, 86077, Pozzilli, Italy.
Fabio ButtariI.R.C.C.S. I.N.M. Neuromed, via Atinense 18, 86077, Pozzilli, Italy.
Edoardo FravigaStem Cell and Neurogenesis Unit, Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.
Vania BroccoliStem Cell and Neurogenesis Unit, Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.
Mirco FanelliDepartment of Biomolecular Sciences, University of Urbino "Carlo Bo", Urbino, Italy.
Francesco FornaiI.R.C.C.S. I.N.M. Neuromed, via Atinense 18, 86077, Pozzilli, Italy.
Stefano GambardellaI.R.C.C.S. I.N.M. Neuromed, via Atinense 18, 86077, Pozzilli, Italy. stefano.gambardella@uniurb.it.ORCID http://orcid.org/0000-0002-3727-4502
Istituto Neurologico Mediterraneo · ITUniversity of Rome Tor Vergata · ITUniversity of Urbino · ITVita-Salute San Raffaele University · ITFondazione Santa Lucia · ITUniversity of Pisa · IT

Funding

Ministero della Salute (IT) Partially Supported By Ministry Of Health (Current Research 2019-2023- Principal Investigator: Identification Of New Variants And / Or New Genes Responsible For Ataxia And Spastic Paraplegia)
6 · The paper itself

Abstract

backgroundLeukodystrophies are familial heterogeneous disorders primarily affecting the white matter, which are defined as hypomyelinating or demyelinating based on disease severity as assessed at MRI. Recently, a group of clinically overlapping hypomyelinating leukodystrophies (HL) has been associated with mutations in RNA polymerase III enzymes (Pol III) subunits. CASE PRESENTATION: In this manuscript, we describe two Italian siblings carrying a novel POLR3A genotype. MRI imaging, genetic analysis, and clinical data led to diagnosing HL type 7. The female sibling, at the age of 34, is tetra-paretic and suffers from severe cognitive regression. She had a disease onset at the age of 19, characterized by slow and progressive cognitive impairment associated with gait disturbances and amenorrhea. The male sibling was diagnosed during an MRI carried out for cephalalgia at the age of 41. After 5 years, he developed mild cognitive impairment, dystonia with 4-limb hypotonia, and moderate dysmetria with balance and gait impairment.

conclusionsThe present study provides the first evidence of unusually late age of onset in HL, describing two siblings with a novel POLR3A genotype which showed the first symptoms at the age of 41 and 19, respectively. This provides a powerful insight into clinical heterogeneity and genotype-phenotype correlation in POLR3A related HL.

Indexed as

AdultAge of OnsetBrainFemaleGenotypeHereditary Central Nervous System Demyelinating DiseasesHumansMagnetic Resonance ImagingMaleMutationRNA Polymerase IIISiblingsWhite MatterPOLR3A protein, humanRNA Polymerase IIIAge of onsetBrainHypomyelinating leukodystrophiesPOLR3A mutations

Identifiers

PMID32600288
PMCPMC7322863
OpenAlexW3037980330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.